On August 14, 2014, the U. S. Food and Drug Administration approved bevacizumab solution for intravenous infusion (Avastin, Genentech, Inc.) for the treatment of persistent, recurrent or metastatic cervical cancer, in combination with paclitaxel and cisplatin or...
Federal House Health Aides Federal Senate Health Aides Impact of Sequestration on Cancer Drugs Sequestration Talking Points – Joint Sponsors Survey on the Impact of Sequestration on Community Cancer Care – Summary of Results – Released March 14, 2013...
How well you and your doctor talk to each other is one of the most important parts of getting good health care. Unfortunately, talking with your doctor isn’t always easy. In the past, the doctor typically took the lead and the patient followed. Today, a good...
Today, the U.S. Food and Drug Administration approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated lungs that do not initially meet the standard criteria for lung transplantation but may be transplantable if there is more time...
